This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Japan Blood Products Organization, Mitsubishi Pharma Corporation. Active years: 2007-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2019
Title: Shusei Uno: Innovator in Biotechnology
Introduction
Shusei Uno is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins and therapeutic agents. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Uno's latest patents include innovative technologies that address critical health issues. One of his notable inventions is a recombinant fibrinogen high-production line and method for producing the same. This invention provides a recombinant strain that highly produces fibrinogen, which is essential for blood clotting. The method involves coexpressing fibrinogen and specific genes in an animal cell, leading to efficient production and recovery of fibrinogen from cultures.
Another significant patent focuses on cell death inducers for mast cells. This invention presents a preventive and therapeutic agent for diseases involving mast cells. It features a fusion protein that includes a PTD and an MITF variant as active ingredients. The actions of this fusion protein include inhibiting the activity of endogenous MITF and inducing apoptosis in mature mast cells, which could be crucial for treating various mast cell-related conditions.
Career Highlights
Throughout his career, Shusei Uno has worked with reputable organizations, including the Japan Blood Products Organization and Mitsubishi Pharma Corporation. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in biotechnology.
Collaborations
Uno has collaborated with notable colleagues, including Kouji Murakami and Momoko Otaki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Shusei Uno's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile